Koers Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Aandelen
300357
CNE100001R58
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,69 CNY | +1,46% | +3,95% | -18,31% |
Omzet 2024 * | 1,05 mld. 144 mln. 135 mln. | Omzet 2025 * | 1,31 mld. 180 mln. 168 mln. | Marktkapitalisatie | 12,4 mld. 1,71 mld. 1,6 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 379 mln. 52,31 mln. 48,91 mln. | Nettowinst (verlies) 2025 * | 497 mln. 68,59 mln. 64,14 mln. | EV/omzet 2024 * | 11,5 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 9,5 x |
K/w-verhouding 2024 * |
29,9
x | K/w-verhouding 2025 * |
24,4
x | Werknemers | 1.709 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 49,91% |
1 dag | +1,46% | ||
1 week | +3,95% | ||
Lopende maand | +4,22% | ||
1 maand | +0,94% | ||
3 maanden | -1,37% | ||
6 maanden | -11,04% | ||
Lopend jaar | -18,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Geng Xi Hu
CEO | Chief Executive Officer | 60 | 19-09-02 |
Guo Qi Wang
DFI | Director of Finance/CFO | 50 | 06-04-16 |
Tao Jin
CHM | Chairman | 38 | 01-08-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geng Xi Hu
CEO | Chief Executive Officer | 60 | 19-09-02 |
Ni Chen Yan
BRD | Director/Board Member | 59 | 28-01-11 |
Lu Zhang
BRD | Director/Board Member | 45 | 28-01-11 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.50% | 2 M€ | -16,59% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 23,69 | +1,46% | 6 055 600 |
25-04-24 | 23,35 | +0,39% | 4 602 100 |
24-04-24 | 23,26 | -0,04% | 5 108 442 |
23-04-24 | 23,27 | +2,33% | 5 543 728 |
22-04-24 | 22,74 | +2,90% | 6 427 262 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,31% | 1,69 mld. | |
+25,78% | 653 mld. | |
+27,00% | 556 mld. | |
-6,68% | 354 mld. | |
+20,34% | 331 mld. | |
+3,04% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-5,92% | 144 mld. |